Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. They may also be called vermifuges (those that stun) or vermicides (those that kill). Anthelmintics are used to treat people who are infected by helminths, a condition called helminthiasis. These drugs are also used to treat infected animals.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Anthelmintic Drugs industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Oral Drugs
Injectables
Market Segment by Product Application
For Human
For Animal
Finally, the report provides detailed profile and data information analysis of leading company.
Novartis
Pfizer
Bayer
Cipla
Sun Pharmaceutical Industries
Mankind Pharma
Johnson & Johnson
Merck
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Anthelmintic Drugs consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Anthelmintic Drugs market by identifying its various subsegments.
3.Focuses on the key global Anthelmintic Drugs manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Anthelmintic Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Anthelmintic Drugs submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Anthelmintic Drugs Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Anthelmintic Drugs Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Anthelmintic Drugs Segment by Type
2.1.1 Oral Drugs
2.1.2 Injectables
2.2 Market Analysis by Application
2.2.1 For Human
2.2.2 For Animal
2.3 Global Anthelmintic Drugs Market Comparison by Regions (2017-2027)
2.3.1 Global Anthelmintic Drugs Market Size (2017-2027)
2.3.2 North America Anthelmintic Drugs Status and Prospect (2017-2027)
2.3.3 Europe Anthelmintic Drugs Status and Prospect (2017-2027)
2.3.4 China Anthelmintic Drugs Status and Prospect (2017-2027)
2.3.5 Japan Anthelmintic Drugs Status and Prospect (2017-2027)
2.3.6 Southeast Asia Anthelmintic Drugs Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Anthelmintic Drugs Industry Impact
2.5.1 Anthelmintic Drugs Business Impact Assessment - Covid-19
2.5.2 Market Trends and Anthelmintic Drugs Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Anthelmintic Drugs Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Anthelmintic Drugs Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Anthelmintic Drugs Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Anthelmintic Drugs Manufacturer Market Share
3.5 Top 10 Anthelmintic Drugs Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Anthelmintic Drugs Market
3.7 Key Manufacturers Anthelmintic Drugs Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Anthelmintic Drugs Industry Key Manufacturers
4.1 Novartis
4.1.1 Compan Detail
4.1.2 Novartis Anthelmintic Drugs Product Introduction, Application and Specification
4.1.3 Novartis 134 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Novartis News
4.2 Pfizer
4.2.1 Compan Detail
4.2.2 Pfizer Anthelmintic Drugs Product Introduction, Application and Specification
4.2.3 Pfizer Anthelmintic Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Novartis News
4.3 Bayer
4.3.1 Compan Detail
4.3.2 Bayer Anthelmintic Drugs Product Introduction, Application and Specification
4.3.3 Bayer Anthelmintic Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Bayer News
4.4 Cipla
4.4.1 Compan Detail
4.4.2 Cipla Anthelmintic Drugs Product Introduction, Application and Specification
4.4.3 Cipla Anthelmintic Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Cipla News
4.5 Sun Pharmaceutical Industries
4.5.1 Compan Detail
4.5.2 Cipla Anthelmintic Drugs Product Introduction, Application and Specification
4.5.3 Sun Pharmaceutical Industries Anthelmintic Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Sun Pharmaceutical Industries News
4.6 Mankind Pharma
4.6.1 Compan Detail
4.6.2 Mankind Pharma Anthelmintic Drugs Product Introduction, Application and Specification
4.6.3 Mankind Pharma Anthelmintic Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Mankind Pharma News
4.7 Johnson & Johnson
4.7.1 Compan Detail
4.7.2 Johnson & Johnson Anthelmintic Drugs Product Introduction, Application and Specification
4.7.3 Johnson & Johnson Anthelmintic Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Merck
4.8.1 Compan Detail
4.8.2 Merck Anthelmintic Drugs Product Introduction, Application and Specification
4.8.3 Merck Anthelmintic Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Merck News
5 Global Anthelmintic Drugs Market Segment by Big Type
5.1 Global Anthelmintic Drugs Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Anthelmintic Drugs Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Anthelmintic Drugs Revenue and Market Share by Big Type (2017-2022)
5.2 Oral Drugs Sales Growth Rate and Price
5.2.1 Global Oral Drugs Sales Growth Rate (2017-2022)
5.2.2 Global Oral Drugs Price (2017-2022)
5.3 Injectables Sales Growth Rate and Price
5.3.1 Global Injectables Sales Growth Rate (2017-2022)
5.3.2 Global Injectables Price (2017-2022)
6 Global Anthelmintic Drugs Market Segment by Big Application
6.1 Global Anthelmintic Drugs Sales Market Share by Big Application (2017-2022)
6.2 For Human Sales Growth Rate (2017-2022)
6.3 For Animal Sales Growth Rate (2017-2022)
7 Global Anthelmintic Drugs Forecast
7.1 Global Anthelmintic Drugs Revenue, Sales and Growth Rate (2022-2027)
7.2 Anthelmintic Drugs Market Forecast by Regions (2022-2027)
7.2.1 North America Anthelmintic Drugs Market Forecast (2022-2027)
7.2.2 Europe Anthelmintic Drugs Market Forecast (2022-2027)
7.2.3 China Anthelmintic Drugs Market Forecast (2022-2027)
7.2.4 Japan Anthelmintic Drugs Market Forecast (2022-2027)
7.2.5 Southeast Asia Anthelmintic Drugs Market Forecast (2022-2027)
7.2.6 Other Regions Anthelmintic Drugs Market Forecast (2022-2027)
7.3 Anthelmintic Drugs Market Forecast by Type (2022-2027)
7.3.1 Global Anthelmintic Drugs Sales Forecast by Type (2022-2027)
7.3.2 Global Anthelmintic Drugs Market Share Forecast by Type (2022-2027)
7.4 Anthelmintic Drugs Market Forecast by Application (2022-2027)
7.4.1 Global Anthelmintic Drugs Sales Forecast by Application (2022-2027)
7.4.2 Global Anthelmintic Drugs Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Anthelmintic Drugs Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Anthelmintic Drugs Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Anthelmintic Drugs
Figure Market Concentration Ratio and Market Maturity Analysis of Anthelmintic Drugs
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Anthelmintic Drugs Market Size by Big Type
Figure Global Market Share of Anthelmintic Drugs by Big Type in 2021
Figure Oral Drugs Picture (2017-2022)
Global Anthelmintic Drugs Market Size by Big Application
Table Global Anthelmintic Drugs Market Size by Application
Figure Global Anthelmintic Drugs Market Share by Big Application in 2021
Figure For Human Picture
Figure For Animal Picture
Table Global Anthelmintic Drugs Comparison by Regions (M USD) (2017-2027)
Figure Global Anthelmintic Drugs Market Size (Million US$) (2017-2027)
Figure North America Anthelmintic Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Anthelmintic Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure China Anthelmintic Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Anthelmintic Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Anthelmintic Drugs Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Anthelmintic Drugs Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Anthelmintic Drugs Sales by Manufacturer (2017-2022)
Figure Global Anthelmintic Drugs Sales Market Share by Manufacturer in 2021
Table Global Anthelmintic Drugs Revenue by Manufacturer (2017-2022)
Figure Global Anthelmintic Drugs Revenue Market Share by Manufacturer in 2021
Table Global Anthelmintic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Anthelmintic Drugs Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Anthelmintic Drugs Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Anthelmintic Drugs Market
Table Key Manufacturers Anthelmintic Drugs Product Type
Table Mergers & Acquisitions Planning
Table Novartis Company Profile
Table Anthelmintic Drugs Product Introduction, Application and Specification of Novartis
Table Anthelmintic Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Pfizer Company Profile
Table Anthelmintic Drugs Product Introduction, Application and Specification of Pfizer
Table Anthelmintic Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pfizer Recent Development
Table Bayer Company Profile
Table Anthelmintic Drugs Product Introduction, Application and Specification of Bayer
Table Anthelmintic Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Bayer Main Business
Table Bayer Recent Development
Table Cipla Company Profile
Table Anthelmintic Drugs Product Introduction, Application and Specification of Cipla
Table Anthelmintic Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Cipla Main Business
Table Cipla Recent Development
Table Cipla Main Business
Table Cipla Recent Development
Table Sun Pharmaceutical Industries Company Profile
Table Anthelmintic Drugs Product Introduction, Application and Specification of Sun Pharmaceutical Industries
Table Anthelmintic Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sun Pharmaceutical Industries Main Business
Table Sun Pharmaceutical Industries Recent Development
Table Mankind Pharma Company Profile
Table Anthelmintic Drugs Product Introduction, Application and Specification of Mankind Pharma
Table Anthelmintic Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Mankind Pharma Main Business
Table Mankind Pharma Recent Development
Table Johnson & Johnson Company Profile
Table Anthelmintic Drugs Product Introduction, Application and Specification of Johnson & Johnson
Table Anthelmintic Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Merck Company Profile
Table Anthelmintic Drugs Product Introduction, Application and Specification of Merck
Table Anthelmintic Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck Main Business
Table Merck Recent Development
Figure Global Anthelmintic Drugs Sales and Growth Rate (2017-2022)
Figure Global Anthelmintic Drugs Revenue and Growth Rate (2017-2022)
Table Global Anthelmintic Drugs Sales by Regions (2017-2022)
Figure Global Anthelmintic Drugs Sales Market Share by Regions in 2021
Table Global Anthelmintic Drugs Revenue by Regions (2017-2022)
Figure Global Anthelmintic Drugs Revenue Market Share by Regions in 2021
Figure North America Anthelmintic Drugs Sales and Growth Rate (2017-2022)
Figure Europe Anthelmintic Drugs Sales and Growth Rate (2017-2022)
Figure China Anthelmintic Drugs Sales and Growth Rate (2017-2022)
Figure Japan Anthelmintic Drugs Sales and Growth Rate (2017-2022)
Figure Southeast Asia Anthelmintic Drugs Sales and Growth Rate (2017-2022)
Figure Other Regions Anthelmintic Drugs Sales and Growth Rate (2017-2022)
Table Global Anthelmintic Drugs Sales by Big Type (2017-2022)
Table Global Anthelmintic Drugs Sales Market Share by Big Type (2017-2022)
Figure Global Anthelmintic Drugs Sales Market Share by Big Type in 2019
Table Global Anthelmintic Drugs Revenue by Big Type (2017-2022)
Table Global Anthelmintic Drugs Revenue Market Share by Big Type (2017-2022)
Table Global Anthelmintic Drugs Revenue Market Share by Big Type in 2019
Figure Global Oral Drugs Sales Growth Rate (2017-2022)
Figure Global Oral Drugs Price (2017-2022)
Figure Global Injectables Sales Growth Rate (2017-2022)
Table Global Anthelmintic Drugs Sales by Big Application (2017-2022)
Table Global Anthelmintic Drugs Sales Market Share by Big Application (2017-2022)
Figure Global Anthelmintic Drugs Sales Market Share by Big Application in 2019
Figure Global For Human Sales Growth Rate (2017-2022)
Figure Global For Animal Sales Growth Rate (2017-2022)
Figure Global Anthelmintic Drugs Sales and Growth Rate (2022-2027)
Figure Global Anthelmintic Drugs Revenue and Growth Rate (2022-2027)
Table Global Anthelmintic Drugs Sales Forecast by Regions (2022-2027)
Table Global Anthelmintic Drugs Market Share Forecast by Regions (2022-2027)
Figure North America Sales Anthelmintic Drugs Market Forecast (2022-2027)
Figure Europe Sales Anthelmintic Drugs Market Forecast (2022-2027)
Figure China Sales Anthelmintic Drugs Market Forecast (2022-2027)
Figure Japan Sales Anthelmintic Drugs Market Forecast (2022-2027)
Figure Southeast Asia Sales Anthelmintic Drugs Market Forecast (2022-2027)
Figure Other Regions Sales Anthelmintic Drugs Market Forecast (2022-2027)
Table Global Anthelmintic Drugs Sales Forecast by Type (2022-2027)
Table Global Anthelmintic Drugs Market Share Forecast by Type (2022-2027)
Table Global Anthelmintic Drugs Sales Forecast by Application (2022-2027)
Table Global Anthelmintic Drugs Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anthelmintic Drugs
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Anthelmintic Drugs Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Anthelmintic Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Anthelmintic Drugs Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Anthelmintic Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Anthelmintic Drugs Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Anthelmintic Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Anthelmintic Drugs Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Anthelmintic Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Novartis
Pfizer
Bayer
Cipla
Sun Pharmaceutical Industries
Mankind Pharma